Skip Navigation
Skip to contents

Headache and Pain Research : Headache and Pain Research

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Headache Pain Res > Ahead of print > Article
Letter to the Editor
 Comment on “Subjective Cognitive Decline Patterns in Patients with Migraine, with or without Depression, versus Non-depressed Older Adults”
Jong-Hee Sohnorcid

DOI: https://doi.org/10.62087/hpr.2026.0023
Published online: June 18, 2026

Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea

Correspondence: Jong-Hee Sohn, M.D., Ph.D. Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, 77 Sakju-ro, Chuncheon 24253, Republic of Korea Tel: +82-33-252-9970, Fax: +82-33-241-8063, E-mail: deepfoci@hallym.or.kr
• Received: May 25, 2026   • Revised: May 27, 2026   • Accepted: May 28, 2026

© 2026 The Korean Headache Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 47 Views
  • 1 Download
Full Article

Download PDF Download PDF

I read with great interest the article by Lee and Cho,1 “Subjective Cognitive Decline Patterns in Patients with Migraine, with or without Depression, versus Non-depressed Older Adults,” published in Headache and Pain Research. The authors reported that, although patients with migraine and depression were younger and had higher educational attainment, their subjective cognitive decline questionnaire (SCD-Q) scores were comparable to those of older adults without depression and were significantly higher than those of patients with migraine without depression (mean SCD-Q scores: 10.39±5.39, 10.11±5.55, and 6.79±3.80, respectively). I commend the authors for examining SCD, a frequently overlooked interictal symptom, in young patients with migraine. Although this observation is clinically meaningful, several methodological and interpretive issues may limit the conclusions that can be drawn.
First, as the authors correctly noted in the limitations section, objective cognitive function was assessed differently across the two clinic populations. Participants from the memory clinic underwent the Seoul Neuropsychological Screening Battery-II, a comprehensive battery with normative data across multiple cognitive domains. In contrast, participants from the headache clinic completed only the Korean Mini-Mental State Examination and Korean Montreal Cognitive Assessment as screening tools.2,3 These brief instruments are known to have ceiling effects in younger individuals with higher educational attainment, who constituted most of the headache clinic group. Therefore, the absence of differences in objective cognitive scores between patients with migraine with and without depression may reflect the limited sensitivity of the screening tools rather than true cognitive equivalence. This issue raises a fundamental concern: the “cognitively normal” classification applied to the headache clinic cohort may not be directly comparable to the classification applied to the memory clinic cohort.
Second, cross-group comparability was further limited by the use of different depression instruments. The Short-form Geriatric Depression Scale was used in the memory clinic population, whereas the Patient Health Questionnaire-9 (PHQ-9) was used in the headache clinic population.4,5 These scales differ in both psychometric properties and conceptual emphasis. The Short-form Geriatric Depression Scale was developed for older adults and places less emphasis on somatic symptoms. By contrast, the PHQ-9 includes somatic items that may systematically inflate depression scores in patients with migraine, a condition characterized by substantial somatic burden. Because different scales were used across groups, direct comparisons of depression severity—and, by extension, the thresholds used to classify participants as “non-depressed”—are inherently problematic. Although the authors acknowledged this limitation, they did not fully discuss how it may have introduced classification bias within each group.
Third, the potential confounding effect of headache-specific characteristics on SCD-Q scores warrants careful consideration. Migraine is associated with interictal cognitive symptoms, including difficulties in attention, working memory, and executive function. These symptoms may vary according to headache frequency, medication use, and chronicity.6,7 The authors stated that headache characteristics, including frequency, chronicity, and treatment, were not collected for the present analysis. The omission of medication overuse as a covariate may be particularly important because medication overuse is common in clinic-based migraine populations and is independently associated with cognitive complaints and mood disturbance. Without adjustment for these migraine-specific factors, it is difficult to determine whether the elevated SCD-Q scores in patients with migraine and depression reflect depression-related cognitive bias, headache-related cognitive dysfunction, medication effects, or a combination of these factors.
Fourth, the authors’ conclusion that individuals with migraine and depression warrant heightened surveillance for cognitive decline is clinically intuitive but should be interpreted cautiously. The findings suggest that comorbid depression may amplify subjective cognitive vulnerability in patients with migraine, consistent with the well-established influence of affective symptoms on self-perceived cognitive function. However, a recent large meta-analysis found that higher depressive symptoms in individuals with SCD did not independently increase the risk of progression to dementia, whereas anxiety and SCD-related worry did.8 By extension, elevated SCD-Q scores in patients with migraine and depression may primarily reflect depressive symptomatology, particularly the negative cognitive bias well documented in depression, rather than a preclinical neurodegenerative signal.9 The cross-sectional design of the study precludes inferences about the longitudinal trajectory of cognitive decline in this group. Future prospective studies incorporating neuroimaging biomarkers, comprehensive neuropsychological assessments, and migraine-specific variables are needed to determine whether the observed SCD pattern in patients with migraine and depression has meaningful prognostic implications for future dementia risk.
Despite these concerns, I commend the authors for highlighting a clinically underrecognized intersection among migraine, depression, and subjective cognitive complaints. Their work underscores the need to consider cognitive symptoms in the clinical assessment of young patients with migraine, particularly those with comorbid depression.
  • 1. Lee SH, Cho SJ. Subjective cognitive decline patterns in patients with migraine, with or without depression, versus non-depressed older adults. Headache Pain Res 2024;25:103-110.ArticlePDF
  • 2. Kang Y, Na DL, Hahn S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 1997;15:300-308.
  • 3. Kang Y, Park J, Yu KH, Lee BC. A reliability, validity, and normative study of the Korean-Montreal Cognitive Assessment (K-MoCA) as an instrument for screening of vascular cognitive impairment (VCI). Korean J Clin Psychol 2009;28:549-562.Article
  • 4. Cho MJ, Bae JN, Suh GH, et al. Validation of geriatric depression scale, Korean version (GDS) in the assessment of DSM-III-R major depression. J Korean Neuropsychiatr Assoc 1999;38:48-63.
  • 5. Seo JG, Park SP. Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J Headache Pain 2015;16:65.ArticlePubMedPMCPDF
  • 6. Braganza DL, Fitzpatrick LE, Nguyen ML, Crowe SF. Interictal cognitive deficits in migraine sufferers: a meta-analysis. Neuropsychol Rev 2022;32:736-757.ArticlePubMedPDF
  • 7. Begasse de Dhaem O, Robbins MS. Cognitive impairment in primary and secondary headache disorders. Curr Pain Headache Rep 2022;26:391-404.ArticlePubMedPMCPDF
  • 8. Desai R, Whitfield T, Said G, et al. Affective symptoms and risk of progression to mild cognitive impairment or dementia in subjective cognitive decline: a systematic review and meta-analysis. Ageing Res Rev 2021;71:101419.ArticlePubMed
  • 9. Jessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline. Lancet Neurol 2020;19:271-278.ArticlePubMedPMC

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • ePub LinkePub Link
      • Cite this Article
        Cite this Article
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Comment on “Subjective Cognitive Decline Patterns in Patients with Migraine, with or without Depression, versus Non-depressed Older Adults”
        Close
      • XML DownloadXML Download
      Related articles
      Comment on “Subjective Cognitive Decline Patterns in Patients with Migraine, with or without Depression, versus Non-depressed Older Adults”
      Comment on “Subjective Cognitive Decline Patterns in Patients with Migraine, with or without Depression, versus Non-depressed Older Adults”
      Headache and Pain Research : Headache and Pain Research
      © The Korean Headache Society.
      TOP